Cuba’s Soberana vaccine candidate has demonstrated a 62% efficacy rate in a two-dose schedule, BioCubaFarma announced on Saturday. Results are pending for the third...
According to Cuban television reports on Cuba’s vaccine progress, executives from the Center for Genetic Engineering and Biotechnology (CIGB) and the Finlay Vaccine Institute...
Phase III clinical trials of Cuba’s Soberana 02 vaccine for COVID-19 from the Finlay Vaccine Institute will begin after receiving approval from Cuba’s regulatory...
France’s Agence Française de Développement (AFD) (French Development Agency) reported this week that France’s Ambassador to Cuba, Patrice Paoli, met with Dr. Vicente Vérez...